23.12.2024 XGEN Venture closes €180M life sciences fund
Bailey McCann, Opalesque New York:

XGEN Venture, a leading venture capital firm specializing in life sciences investments, has closed its latest life sciences fund on €180M.

The fund focuses on early-stage investments across biotechnology, medical devices, and diagnostics.

XGEN Venture has already begun deploying capital in six startups, just recently adding iOnctura B.V.- a compan

Print